Human medicines European public assessment report (EPAR): Teysuno, tegafur,gimeracil,oteracil, Date of authorisation: 14/03/2011, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Ristaben, sitagliptin, Date of authorisation: 15/03/2010, Revision: 30, Status: Authorised

Antimicrobial Sales and Use (ASU) Platform: Release notes

Human medicines European public assessment report (EPAR): Orkambi, lumacaftor,ivacaftor, Date of authorisation: 19/11/2015, Revision: 38, Status: Authorised

Human medicines European public assessment report (EPAR): M-M-RVaxPro, measles, mumps and rubella vaccine (live), Date of authorisation: 05/05/2006, Revision: 36, Status: Authorised

Cyanokit

Human medicines European public assessment report (EPAR): Vocabria, cabotegravir, Date of authorisation: 17/12/2020, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Palonosetron Accord, palonosetron, Date of authorisation: 26/05/2016, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Zimbus Breezhaler, indacaterol,glycopyrronium,mometasone furoate, Date of authorisation: 03/07/2020, Revision: 8, Status: Authorised